First AD

Second AD

Major Depressive Disorder

Major Depressive Disorder condition center page, resources on the topics of medical news and expert insight into depression can be found. Content includes articles, interviews, videos, podcasts, and breaking news on MDD research, treatment, and drug development.

Evolving Management Strategies for Treatment-Resistant Depression

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Peer Exchange

Recommendations that can help clinicians navigate through the reimbursement process and best support patients who receive intranasal esketamine for treatment-resistant depression. 

Treatment-Resistant Depression: Financial Support for Esketamine Therapy 

Prevalence of Treatment-Resistant Depression 

IV Ketamine for Treatment-Resistant Depression 

Current Guidelines for Managing Treatment-Resistant Depression 

Intranasal Esketamine for Treatment-Resistant Depression 

Esketamine for Treatment-Resistant Depression: Patient Selection Criteria 

Monitoring Patients on Esketamine Therapy for Treatment-Resistant Depression 

Response to Esketamine Therapy for Treatment-Resistant Depression 

REMS Safety Program for Esketamine in Treatment-Resistant Depression 

Treatment-Resistant Depression: Administering Esketamine to Patients 

Getting Certified to Administer Esketamine for Treatment-Resistant Depression 

Incorporating Esketamine into Practice for Treatment-Resistant Depression 

Frontline Psychotherapy for Depression 

Traditional Classes of Antidepressant Therapies 

Electroconvulsive Therapy for Depression 

Integrated Care and Treatment-Resistant Depression 